A processed plant root with a long history of use for memory, mood and sleep. The clearest human signal is better thinking in older adults with measurable decline, and reduced low mood inside traditional multi-herb formulas. Calming and sleep effects rest almost entirely on animal work. The active compounds irritate the throat and gut; processed root with food limits that. (Full Review)

Protocol

Standardized extract, the clinical-trial approach

100 mg three times daily

Ethanolic root extract totalling 300 mg, for four weeks — the only regimen tested in randomized human trials.

Traditional decoction, the pharmacopoeial approach

3–9 g dried root daily

Processed root simmered in water, taken in two or three portions, usually within a multi-herb formula rather than alone.

Best time of day

Breakfast, lunch, dinner or bedtime

Breakfast and lunch doses capture the alerting component; the third at dinner or bedtime captures the sedative one. Split dosing is preferred.

Time to effect

Memory endpoints

4 weeks

Measurable memory endpoints in both randomized trials were assessed only at four weeks, so that is the realistic evaluation window.

Subjective calm-alert effects

30–60 minutes

Reported within 30–60 minutes of a concentrated extract dose.

Benefits

High: Cognitive function

Medium: Depressive symptoms

Low: Sleep onset and sleep continuity; anxiety and stress reactivity; expectorant effect on productive cough

Speculative: Clearance of aggregated neurodegenerative proteins; lifespan extension and oxidative-stress resistance

Contraindications

Pregnancy at any stage and breastfeeding

Active peptic ulcer or endoscopically confirmed erosive gastritis, and inflammatory bowel disease during a flare (faecal calprotectin above 250 µg/g)

Moderate or severe liver impairment (Child-Pugh Class B or C)

Children under 18

Within 14 days of elective surgery under general anaesthesia

Key Interactions

Sedative-hypnotics (zolpidem, zopiclone, temazepam, diazepam)

Cholinesterase inhibitors (donepezil, rivastigmine, galantamine)

Antidepressants (sertraline, fluoxetine, venlafaxine; monoamine oxidase inhibitors such as phenelzine)

Non-steroidal anti-inflammatory drugs (ibuprofen, naproxen, aspirin) and corticosteroids

Over-the-counter sedating antihistamines (diphenhydramine, doxylamine) and antacid or acid-suppressing products

Sedative supplements (valerian, kava, melatonin, ashwagandha, magnolia bark)

Saponin-rich supplements (Panax ginseng, quillaja-containing products, Bacopa monnieri)

Alcohol; ketogenic or extended-fasting protocols

Risk & Side Effects

High: Mucosal irritation of the throat and gastrointestinal tract

Medium: Intestinal barrier disruption and microbiome depletion

Low: Sedation and daytime drowsiness; uterine stimulation relevant to pregnancy

Speculative: Serotonergic additivity with antidepressant drugs; haemolysis from saponin load

Monitoring

Marker	Target	Why
ALT	10–26 U/L	Detects any hepatic response to a multi-component botanical
AST	10–26 U/L	Companion liver marker; separates hepatic from muscle sources
hs-CRP	Below 0.5 mg/L	Tracks the low-grade inflammation the root is proposed to lower
Faecal calprotectin	Below 50 µg/g	The most direct read-out of the root's principal risk: gut lining irritation
Haemoglobin and haptoglobin	Haemoglobin 13.5–15.0 g/dL (men), 12.5–14.5 g/dL (women); haptoglobin 40–200 mg/dL	Screens for the theoretical saponin haemolysis signal
Serum albumin	4.2–5.0 g/dL	Reflects absorptive capacity and gut protein loss during prolonged use

Cadence: Baseline before the first dose; tolerability judged clinically during the first two weeks; repeat bloodwork at 12 weeks, then every six to twelve months; cognitive test repeated at 8 to 12 weeks.

Qualitative Assessment

Recognition memory in daily life — recalling names, where objects were left, and the content of a conversation the following day
Working-memory load — how many threads can be held at once before notes become necessary
Sleep onset latency and morning grogginess, tracked as a simple nightly rating
Mood stability and the subjective "stimulating yet calm" quality, distinguished from jitteriness
Throat sensation, appetite and stool consistency — the earliest tolerability signals

Polygala tenuifolia for Health & Longevity

Protocol

Benefits

Risk & Side Effects

Monitoring

Qualitative Assessment